Mahbubl Ahmed, MSc, MBBS, PhD

Dr Mahbubl Ahmed MRCP PhD FRCR
University College London Hospitals NHS Foundation Trust
London, England, United Kingdom

Presentation(s):

• Paper 45 - LONG-TERM EFFICACY AND SAFETY OF VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT): RESULTS FROM THE MOTION PHASE 3 TRIAL

  Friday, November 14, 2025
  2:30 PM - 3:30 PM EST

  Disclosure information not submitted.